MARKET NEWS

Double Chamber Prefilled Syringes Market Likely to be Driven by Growing Requirement of Highly Efficient Parental Drug Delivery Modes
Oxford BioTherapeutics Announces Receipt of Milestone Payment From Boehringer Ingelheim
Intensity Therapeutics Announces Clinical Collaboration With Merck
Athenex Announces US FDA Allowance of IND Application
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial, Receives RMAT Designation
Janssen Announces Collaboration to Expand Data Science Research in Healthcare

  FEATURED EDITORIAL

  COMPANY PROFILE

Credence MedSystems is setting a new standard in drug delivery, helping you differentiate your products through innovative delivery systems while preserving your trusted processes. Simple, safe, and intuitive usability creates a better, safer experience for patients and healthcare professionals. Innovative designs provide safety activation clicks, end-of-dose feedback cues, and automatic needle retraction—without changes to familiar injection procedures. Click here for more.

  EXCLUSIVE ONLINE CONTENT

2019 Respiratory Drug Development eBook - Increased Focus on Respiratory Drug & Device Development Makes Treatment More Personal

2019 Respiratory Drug Development eBook - Increased Focus on Respiratory Drug & Device Development Makes Treatment More Personal

This e-Book highlights some of the innovators and innovations in the respiratory sector, addresses the importance of end users in the device development process, and presents recent advancements in improving patient adherence.

From ASCO 2019: TILs a Cause for Hope in Melanoma, Cervical & Breast Cancers

From ASCO 2019: TILs a Cause for Hope in Melanoma, Cervical & Breast Cancers

As the Spring heat made the light dance around the skin of the largest convention center in America, winners emerged from ASCO last month. One of the most significant announcements (from Iovance Biotherapeutics Inc.) were two first-in-man studies of adoptive T cell therapy (ACT) in patients with melanoma and cervical cancer which had failed to respond to other treatments.

Designing a CMC Strategy for Accelerated Development of Biotherapeutics

Designing a CMC Strategy for Accelerated Development of Biotherapeutics

As the pipeline of biologic drugs intended to treat complex disease expands, the typical timeline for drug development seems to be shortening more frequently and with more intensity……..

AbbVie Attempts to Secure Long-Term Growth Via Allergan Mega-Merger

AbbVie Attempts to Secure Long-Term Growth Via Allergan Mega-Merger

Following the news that AbbVie has acquired Allergan for $63 billion, Maura Musciacco, MSc, Senior Director of Neurology & Ophthalmology at GlobalData, a leading data and analytics company, offers her view on this mega-merger.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

July 17 – Parenteral Contract Manufacturing
July 24 – Bioavailability